AKT1 and neoplasm: In previous studies, DEHP has been proven to promote the cell growth and drug resistance of different tumor cells through various signaling pathways, such as ERK, JAK2/STAT3, PI3K/Akt, etc. (Chen et al. 2013, Hsieh et al. 2022, Zhang et al. 2022).